Cargando…
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097043/ https://www.ncbi.nlm.nih.gov/pubmed/30546093 http://dx.doi.org/10.1038/s41564-018-0295-3 |
_version_ | 1783510945196146688 |
---|---|
author | Land, Kevin J. Boeras, Debrah I. Chen, Xiang-Sheng Ramsay, Andrew R. Peeling, Rosanna W. |
author_facet | Land, Kevin J. Boeras, Debrah I. Chen, Xiang-Sheng Ramsay, Andrew R. Peeling, Rosanna W. |
author_sort | Land, Kevin J. |
collection | PubMed |
description | Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes. |
format | Online Article Text |
id | pubmed-7097043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70970432020-03-26 REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes Land, Kevin J. Boeras, Debrah I. Chen, Xiang-Sheng Ramsay, Andrew R. Peeling, Rosanna W. Nat Microbiol Perspective Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes. Nature Publishing Group UK 2018-12-13 2019 /pmc/articles/PMC7097043/ /pubmed/30546093 http://dx.doi.org/10.1038/s41564-018-0295-3 Text en © Springer Nature Limited 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Perspective Land, Kevin J. Boeras, Debrah I. Chen, Xiang-Sheng Ramsay, Andrew R. Peeling, Rosanna W. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title | REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title_full | REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title_fullStr | REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title_full_unstemmed | REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title_short | REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
title_sort | reassured diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097043/ https://www.ncbi.nlm.nih.gov/pubmed/30546093 http://dx.doi.org/10.1038/s41564-018-0295-3 |
work_keys_str_mv | AT landkevinj reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes AT boerasdebrahi reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes AT chenxiangsheng reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes AT ramsayandrewr reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes AT peelingrosannaw reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes |